These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17445787)

  • 1. Evolutionary deimmunization: an ancillary mechanism for self-tolerance?
    De Groot AS; Goldberg M; Moise L; Martin W
    Cell Immunol; 2006 Dec; 244(2):148-53. PubMed ID: 17445787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.
    Bian H; Hammer J
    Methods; 2004 Dec; 34(4):468-75. PubMed ID: 15542373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.
    Bazhan SI; Karpenko LI; Lebedev LR; Uzhachenko RV; Belavin PA; Eroshkin AM; Ilyichev AA
    Mol Immunol; 2008 Feb; 45(3):661-9. PubMed ID: 17869341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
    Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
    Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics and immunologic investigation on B and T cell epitopes of Cur l 3, a major allergen of Curvularia lunata.
    Sharma V; Singh BP; Gaur SN; Pasha S; Arora N
    J Proteome Res; 2009 Jun; 8(6):2650-5. PubMed ID: 19290623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of autoimmunity.
    Atassi MZ; Casali P
    Autoimmunity; 2008 Mar; 41(2):123-32. PubMed ID: 18324481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function.
    Sawatani Y; Miyamoto T; Nagai S; Maruya M; Imai J; Miyamoto K; Fujita N; Ninomiya K; Suzuki T; Iwasaki R; Toyama Y; Shinohara M; Koyasu S; Suda T
    Int Immunol; 2008 Oct; 20(10):1259-68. PubMed ID: 18653699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning to be tolerant: how T cells keep out of trouble.
    Holländer GA; Peterson P
    J Intern Med; 2009 May; 265(5):541-61. PubMed ID: 19382993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.
    Piesche M; Hildebrandt Y; Chapuy B; Wulf GG; Trümper L; Schroers R
    Vaccine; 2009 Jul; 27(34):4718-23. PubMed ID: 19446593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
    Odunsi K; Qian F; Matsuzaki J; Mhawech-Fauceglia P; Andrews C; Hoffman EW; Pan L; Ritter G; Villella J; Thomas B; Rodabaugh K; Lele S; Shrikant P; Old LJ; Gnjatic S
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12837-42. PubMed ID: 17652518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomics: discovering new targets for vaccines and therapeutics.
    De Groot AS
    Drug Discov Today; 2006 Mar; 11(5-6):203-9. PubMed ID: 16580597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary distance from human homologs reflects allergenicity of animal food proteins.
    Jenkins JA; Breiteneder H; Mills EN
    J Allergy Clin Immunol; 2007 Dec; 120(6):1399-405. PubMed ID: 17935767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II antigen presentation by prostate cancer cells.
    Younger AR; Amria S; Jeffrey WA; Mahdy AE; Goldstein OG; Norris JS; Haque A
    Prostate Cancer Prostatic Dis; 2008; 11(4):334-41. PubMed ID: 17938645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.